Healthcare
Sunday, August 21, 2016
UPDATE 1-Pfizer nears deal to acquire Medivation for close to $14 bln -sources
Aug 21 (Reuters) - Pfizer Inc is in advanced talks
to acquire U.S. cancer drug company Medivation Inc for
close to $14 billion, as it seeks to boost its oncology
portfolio, people familiar with the matter said on Sunday.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment